Skip to main content
Erschienen in: Acta Neuropathologica 1/2013

01.01.2013 | Original Paper

Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients

verfasst von: Adina N. Lazar, Claudia Bich, Maï Panchal, Nicolas Desbenoit, Vanessa W. Petit, David Touboul, Luce Dauphinot, Catherine Marquer, Olivier Laprévote, Alain Brunelle, Charles Duyckaerts

Erschienen in: Acta Neuropathologica | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Although cholesterol has been involved in the pathophysiology of Alzheimer disease (AD), its distribution in the cerebral cortex over the course of AD is unknown. We describe an original method to quantify cholesterol distribution using time-of-flight secondary ion mass spectrometry imaging. Cholesterol was unevenly distributed along the cortical thickness, being more abundant close to the white matter, in both control and AD cases. However, the mean cholesterol signal was significantly higher in the lower half of the cortex in AD samples compared to controls. This increase, when converted into cortical layers, was statistically significant for layers III and IV and did not reach significance in layers V + VI, the variability being too high at the interface between grey and white matter. The density of neurofibrillary tangles and of senile plaques was not statistically linked to the abundance of cholesterol. Cholesterol overload thus appears a new and independent alteration of AD cerebral cortex. The structure in which cholesterol accumulates and the mechanism of this accumulation remain to be elucidated.
Literatur
1.
Zurück zum Zitat Armstrong RA (2006) Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21(3):175–181PubMedCrossRef Armstrong RA (2006) Laminar distribution of beta-amyloid deposits in dementia with Lewy bodies and in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 21(3):175–181PubMedCrossRef
2.
Zurück zum Zitat Börner K, Nygren H, Hagenhoff B, Malmberg P, Tallarek E, Mansson JE (2006) Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim Biophys Acta 1761(3):335–344PubMedCrossRef Börner K, Nygren H, Hagenhoff B, Malmberg P, Tallarek E, Mansson JE (2006) Distribution of cholesterol and galactosylceramide in rat cerebellar white matter. Biochim Biophys Acta 1761(3):335–344PubMedCrossRef
3.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259PubMedCrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259PubMedCrossRef
4.
Zurück zum Zitat Candy JM, Oakley AE, Mountfort SA, Taylor GA, Morris CM, Bishop HE, Edwardson JA (1992) The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell 74(1):109–118PubMedCrossRef Candy JM, Oakley AE, Mountfort SA, Taylor GA, Morris CM, Bishop HE, Edwardson JA (1992) The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell 74(1):109–118PubMedCrossRef
5.
Zurück zum Zitat Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O’Hare EO, Wood WG (2001) Amyloid beta-peptide1–40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42(8):1292–1297PubMed Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O’Hare EO, Wood WG (2001) Amyloid beta-peptide1–40 increases neuronal membrane fluidity: role of cholesterol and brain region. J Lipid Res 42(8):1292–1297PubMed
6.
Zurück zum Zitat Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923PubMedCrossRef Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923PubMedCrossRef
7.
Zurück zum Zitat Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer’s disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801(8):839–845PubMedCrossRef Cossec JC, Marquer C, Panchal M, Lazar AN, Duyckaerts C, Potier MC (2010) Cholesterol changes in Alzheimer’s disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta 1801(8):839–845PubMedCrossRef
8.
Zurück zum Zitat Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801(8):846–852PubMedCrossRef Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801(8):846–852PubMedCrossRef
9.
Zurück zum Zitat Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA 101(7):2070–2075PubMedCrossRef Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci USA 101(7):2070–2075PubMedCrossRef
10.
Zurück zum Zitat Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw J-J (1989) Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol (Berl) 77(6):645–653CrossRef Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw J-J (1989) Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol (Berl) 77(6):645–653CrossRef
11.
Zurück zum Zitat Distl R, Meske V, Ohm TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 101(6):547–554PubMed Distl R, Meske V, Ohm TG (2001) Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons. Acta Neuropathol 101(6):547–554PubMed
12.
Zurück zum Zitat Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5–36PubMedCrossRef Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118(1):5–36PubMedCrossRef
13.
Zurück zum Zitat Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70(3–4):249–256CrossRef Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70(3–4):249–256CrossRef
14.
Zurück zum Zitat Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257PubMedCrossRef Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257PubMedCrossRef
15.
Zurück zum Zitat Gottfries CG, Karlsson I, Svennerholm L (1996) Membrane components separate early-onset Alzheimer’s disease from senile dementia of the Alzheimer type. Int Psychogeriatr 8(3):365–372PubMedCrossRef Gottfries CG, Karlsson I, Svennerholm L (1996) Membrane components separate early-onset Alzheimer’s disease from senile dementia of the Alzheimer type. Int Psychogeriatr 8(3):365–372PubMedCrossRef
16.
Zurück zum Zitat Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O’Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093PubMedCrossRef Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O’Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093PubMedCrossRef
17.
Zurück zum Zitat Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84(1):45–51CrossRef Hof PR, Delacourte A, Bouras C (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol (Berl) 84(1):45–51CrossRef
18.
Zurück zum Zitat Ikonen E, Parton RG (2000) Caveolins and cellular cholesterol balance. Traffic 1(3):212–217PubMedCrossRef Ikonen E, Parton RG (2000) Caveolins and cellular cholesterol balance. Traffic 1(3):212–217PubMedCrossRef
19.
Zurück zum Zitat Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099PubMedCrossRef Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099PubMedCrossRef
20.
Zurück zum Zitat Lebouvier T, Perruchini C, Panchal M, Potier MC, Duyckaerts C (2009) Cholesterol in the senile plaque: often mentioned, never seen. Acta Neuropathol 117(1):31–34PubMedCrossRef Lebouvier T, Perruchini C, Panchal M, Potier MC, Duyckaerts C (2009) Cholesterol in the senile plaque: often mentioned, never seen. Acta Neuropathol 117(1):31–34PubMedCrossRef
21.
Zurück zum Zitat Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease. A quantitative study of visual and auditory cortices. J Neurosci 7(6):1799–1808PubMed Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease. A quantitative study of visual and auditory cortices. J Neurosci 7(6):1799–1808PubMed
22.
Zurück zum Zitat Majocha RE, Benes FM, Reifel JL, Rodenrys AM, Marotta CA (1988) Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci USA 85(16):6182–6186PubMedCrossRef Majocha RE, Benes FM, Reifel JL, Rodenrys AM, Marotta CA (1988) Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci USA 85(16):6182–6186PubMedCrossRef
23.
Zurück zum Zitat Marquer C, Devauges V, Cossec JC, Liot G, Lecart S, Saudou F, Duyckaerts C, Leveque-Fort S, Potier MC (2011) Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J 25(4):1295–1305PubMedCrossRef Marquer C, Devauges V, Cossec JC, Liot G, Lecart S, Saudou F, Duyckaerts C, Leveque-Fort S, Potier MC (2011) Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J 25(4):1295–1305PubMedCrossRef
24.
Zurück zum Zitat Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11PubMedCrossRef Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123(1):1–11PubMedCrossRef
25.
Zurück zum Zitat Nygren H, Malmberg P, Kriegeskotte C, Arlinghaus HF (2004) Bioimaging TOF-SIMS: localization of cholesterol in rat kidney sections. FEBS Lett 566(1–3):291–293PubMedCrossRef Nygren H, Malmberg P, Kriegeskotte C, Arlinghaus HF (2004) Bioimaging TOF-SIMS: localization of cholesterol in rat kidney sections. FEBS Lett 566(1–3):291–293PubMedCrossRef
26.
Zurück zum Zitat Ohm TG, Treiber-Held S, Distl R, Glockner F, Schonheit B, Tamanai M, Meske V (2003) Cholesterol and tau protein—findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry 36(Suppl 2):S120–S126PubMed Ohm TG, Treiber-Held S, Distl R, Glockner F, Schonheit B, Tamanai M, Meske V (2003) Cholesterol and tau protein—findings in Alzheimer’s and Niemann Pick C’s disease. Pharmacopsychiatry 36(Suppl 2):S120–S126PubMed
27.
Zurück zum Zitat Panchal M, Loeper J, Cossec JC, Perruchini C, Lazar A, Pompon D, Duyckaerts C (2010) Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry. J Lipid Res 51(3):598–605PubMedCrossRef Panchal M, Loeper J, Cossec JC, Perruchini C, Lazar A, Pompon D, Duyckaerts C (2010) Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry. J Lipid Res 51(3):598–605PubMedCrossRef
28.
Zurück zum Zitat Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610(2):271–280PubMedCrossRef Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610(2):271–280PubMedCrossRef
29.
Zurück zum Zitat Puglielli L, Friedlich AL, Setchell KD, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov S, Kovacs DM, Bush AI (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest 115(9):2556–2563PubMedCrossRef Puglielli L, Friedlich AL, Setchell KD, Nagano S, Opazo C, Cherny RA, Barnham KJ, Wade JD, Melov S, Kovacs DM, Bush AI (2005) Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. J Clin Invest 115(9):2556–2563PubMedCrossRef
30.
Zurück zum Zitat Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6(4):345–351PubMedCrossRef Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6(4):345–351PubMedCrossRef
31.
Zurück zum Zitat Quintana C, Wu TD, Delatour B, Dhenain M, Guerquin-Kern JL, Croisy A (2007) Morphological and chemical studies of pathological human and mice brain at the subcellular level: correlation between light, electron, and nanosims microscopies. Microsc Res Tech 70(4):281–295PubMedCrossRef Quintana C, Wu TD, Delatour B, Dhenain M, Guerquin-Kern JL, Croisy A (2007) Morphological and chemical studies of pathological human and mice brain at the subcellular level: correlation between light, electron, and nanosims microscopies. Microsc Res Tech 70(4):281–295PubMedCrossRef
32.
Zurück zum Zitat Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 5(10):2801–2808PubMed Rogers J, Morrison JH (1985) Quantitative morphology and regional and laminar distribution of senile plaques in Alzheimer’s disease. J Neurosci 5(10):2801–2808PubMed
33.
Zurück zum Zitat Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’s disease. Biochemistry 41(37):11080–11090PubMedCrossRef Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, Watson D, Luehrs DC, Sue L, Walker D, Emmerling M, Goux W, Beach T (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer’s disease. Biochemistry 41(37):11080–11090PubMedCrossRef
34.
35.
Zurück zum Zitat Sjövall P, Lausmaa J, Johansson B (2004) Mass spectrometric imaging of lipids in brain tissue. Anal Chem 76(15):4271–4278PubMedCrossRef Sjövall P, Lausmaa J, Johansson B (2004) Mass spectrometric imaging of lipids in brain tissue. Anal Chem 76(15):4271–4278PubMedCrossRef
36.
Zurück zum Zitat Solé-Domènech S, Sjövall P, Vukojevic V, Codita A, Salve S, Schalling V, LaFerla F, Giménez-Llort L, Nilsson P, Hammarström P, Terenius L, Johansson B (2011) Cholesterol accumulates in the vicinity of amyloid-beta deposits in brain tissue. Paper presented at the Alzheimer’s Association International Conference, Paris Solé-Domènech S, Sjövall P, Vukojevic V, Codita A, Salve S, Schalling V, LaFerla F, Giménez-Llort L, Nilsson P, Hammarström P, Terenius L, Johansson B (2011) Cholesterol accumulates in the vicinity of amyloid-beta deposits in brain tissue. Paper presented at the Alzheimer’s Association International Conference, Paris
37.
Zurück zum Zitat Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791–1800PubMedCrossRef Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58(12):1791–1800PubMedCrossRef
38.
Zurück zum Zitat Touboul D, Brunelle A, Laprévote O (2006) Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. Rapid Commun Mass Spectrom 20(4):703–709PubMedCrossRef Touboul D, Brunelle A, Laprévote O (2006) Structural analysis of secondary ions by post-source decay in time-of-flight secondary ion mass spectrometry. Rapid Commun Mass Spectrom 20(4):703–709PubMedCrossRef
39.
Zurück zum Zitat Touboul D, Halgand F, Brunelle A, Kersting R, Tallarek E, Hagenhoff B, Laprévote O (2004) Tissue molecular ion imaging by gold cluster ion bombardment. Anal Chem 76(6):1550–1559PubMedCrossRef Touboul D, Halgand F, Brunelle A, Kersting R, Tallarek E, Hagenhoff B, Laprévote O (2004) Tissue molecular ion imaging by gold cluster ion bombardment. Anal Chem 76(6):1550–1559PubMedCrossRef
40.
Zurück zum Zitat Touboul D, Kollmer F, Niehuis E, Brunelle A, Laprévote O (2005) Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source. J Am Soc Mass Spectrom 16(10):1608–1618PubMedCrossRef Touboul D, Kollmer F, Niehuis E, Brunelle A, Laprévote O (2005) Improvement of biological time-of-flight-secondary ion mass spectrometry imaging with a bismuth cluster ion source. J Am Soc Mass Spectrom 16(10):1608–1618PubMedCrossRef
41.
Zurück zum Zitat Touboul D, Laprévote O, Brunelle A (2011) Micrometric molecular histology of lipids by mass spectrometry imaging. Curr Opin Chem Biol 15(5):725–732PubMedCrossRef Touboul D, Laprévote O, Brunelle A (2011) Micrometric molecular histology of lipids by mass spectrometry imaging. Curr Opin Chem Biol 15(5):725–732PubMedCrossRef
42.
Zurück zum Zitat Weibel ER (1979) Stereological methods. In: Practical methods for biological morphometry, vol 1. Academic Press, London Weibel ER (1979) Stereological methods. In: Practical methods for biological morphometry, vol 1. Academic Press, London
43.
Zurück zum Zitat Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W (2008) Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29(3):422–437PubMedCrossRef Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, Sue LI, Woulfe J, Xu H, Stanimirovic DB, Zhang W (2008) Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29(3):422–437PubMedCrossRef
Metadaten
Titel
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients
verfasst von
Adina N. Lazar
Claudia Bich
Maï Panchal
Nicolas Desbenoit
Vanessa W. Petit
David Touboul
Luce Dauphinot
Catherine Marquer
Olivier Laprévote
Alain Brunelle
Charles Duyckaerts
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 1/2013
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-012-1041-1

Weitere Artikel der Ausgabe 1/2013

Acta Neuropathologica 1/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.